HCWB
HCW Biologics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$19.46M
P/E Ratio
—
EPS
$-8.29
Beta
1.14
52W High
$8.75
52W Low
$0.25
50-Day MA
$0.61
200-Day MA
$2.12
Dividend Yield
—
Profit Margin
-34.70%
Forward P/E
—
PEG Ratio
—
About HCW Biologics Inc
HCW Biologics Inc is a pioneering biotechnology firm focused on advancing immunotherapies and vaccine technologies to tackle critical health issues like cancer and infectious diseases. By utilizing proprietary platforms designed to optimize immune response, the company is developing a promising pipeline of clinical candidates that aim to revolutionize patient treatment. With strategic partnerships and a dedication to fulfilling unmet medical needs, HCW Biologics stands at the forefront of the biotechnology industry, representing a compelling investment opportunity amid the sector's growth.
Fundamentals
| Revenue (TTM) | $6.59M |
| Gross Profit (TTM) | $6.54M |
| EBITDA | $-7.70M |
| Operating Margin | 49.40% |
| Return on Equity | -27726.00% |
| Return on Assets | -19.70% |
| Revenue/Share (TTM) | $2.08 |
| Book Value | $0.84 |
| Price-to-Book | 3.38 |
| Price-to-Sales (TTM) | 2.95 |
| EV/Revenue | 3.764 |
| EV/EBITDA | -3.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 129081.00% |
| Shares Outstanding | $6.73M |
| Float | $6.15M |
| % Insiders | 8.09% |
| % Institutions | 11.50% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026